Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S McKelvie

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Future Cardiology|October 7, 2009
Current and future uses of candesartan in the treatment of heart failureRobert S McKelvie
Heart Failure Reviews|October 26, 2007
Exercise training in patients with heart failure: clinical outcomes, safety, and indicationsRobert S McKelvie
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 8, 2006
Initial data supporting the design of the Candesartan in Heart failure--assessment of reduction in mortality and morbidity (CHARM) programmeRobert S McKelvie
Expert Review of Cardiovascular Therapy|December 25, 2008
The CHARM program: the effects of candesartan for the management of patients with chronic heart failureRobert S McKelvie
Expert Opinion on Pharmacotherapy|October 6, 2006
Candesartan for the management of heart failure: more than an alternativeRobert S McKelvie
Expert Opinion on Investigational Drugs|March 12, 2004
The therapeutic potential of angiotensin II receptor blockers in the treatment of heart failureRobert S McKelvie
Congestive Heart Failure (Greenwich, Conn.)|April 3, 2003
Growth hormone therapy in heart failure: where are we now?Catherine Demers, Robert S McKelvie
Expert Opinion on Investigational Drugs|July 30, 2005
Growth hormone therapy in heart failure: a novel therapy worthy of further consideration?Catherine Demers, Robert S McKelvie
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|November 13, 2008
Cardiovascular aging and exercise in healthy older adultsGeorge A Heckman, Robert S McKelvie
Congestive Heart Failure (Greenwich, Conn.)|January 31, 2003
The role of angiotensin II receptor blockers in the treatment of heart failure patientsMichael Theal, Catherine Demers, Robert S McKelvie
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Future Cardiology|October 7, 2009
Current and future uses of candesartan in the treatment of heart failureRobert S McKelvie
Heart Failure Reviews|October 26, 2007
Exercise training in patients with heart failure: clinical outcomes, safety, and indicationsRobert S McKelvie
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 8, 2006
Initial data supporting the design of the Candesartan in Heart failure--assessment of reduction in mortality and morbidity (CHARM) programmeRobert S McKelvie
Expert Review of Cardiovascular Therapy|December 25, 2008
The CHARM program: the effects of candesartan for the management of patients with chronic heart failureRobert S McKelvie
Expert Opinion on Pharmacotherapy|October 6, 2006
Candesartan for the management of heart failure: more than an alternativeRobert S McKelvie
Expert Opinion on Investigational Drugs|March 12, 2004
The therapeutic potential of angiotensin II receptor blockers in the treatment of heart failureRobert S McKelvie
Congestive Heart Failure (Greenwich, Conn.)|April 3, 2003
Growth hormone therapy in heart failure: where are we now?Catherine Demers, Robert S McKelvie
Expert Opinion on Investigational Drugs|July 30, 2005
Growth hormone therapy in heart failure: a novel therapy worthy of further consideration?Catherine Demers, Robert S McKelvie
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|November 13, 2008
Cardiovascular aging and exercise in healthy older adultsGeorge A Heckman, Robert S McKelvie
Congestive Heart Failure (Greenwich, Conn.)|January 31, 2003
The role of angiotensin II receptor blockers in the treatment of heart failure patientsMichael Theal, Catherine Demers, Robert S McKelvie
Pageof 12